Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZSWIM5P3 is a pseudogene corresponding to the zinc finger SWIM-type containing 5 (ZSWIM5) gene. It does not encode a functional protein and therefore does not participate directly in biological processes or serve as a therapeutic target. Pseudogenes are generally regarded as segments of DNA that resemble functional genes but typically lack protein-coding potential due to mutations or lack of regulatory elements[3]. There are no known roles, interacting drugs, biomarkers, or disease associations specific to ZSWIM5P3. The functional gene, ZSWIM5, encodes a zinc finger SWIM-type domain protein involved in DNA/protein interactions and is reported to have tumor suppressor activity in lung cancer and other normal tissues[1][5]. The pseudogene ZSWIM5P3, however, does not share these functional properties[3]. There is no evidence that ZSWIM5P3 acts as a protein, receptor, enzyme, transporter, or any conventional drug target class. No drugs, mechanisms of action, or clinical biomarker uses are described for ZSWIM5P3. In summary, ZSWIM5P3 is not a protein-coding gene, not a drug target, and does not have reported biological or pathological functions[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger SWIM-type containing 5 pseudogene 3 (ZSWIM5P3).